Harvey Jones has spotted signs of life in the GSK share price. Which is a relief after its recent troubles, so can the FTSE ...

AstraZeneca is making a $1bn investment for the long term, but what lies in store for investors over the next 12 months? Here ...

British investors can leverage the power of an ISA to earn a chunky, long-term second income, entirely tax-free! Zaven ...

GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...

GSK shares are trading cheaply and offering potential passive income. So is this FTSE 100 stock a no-brainer buy for my ...